FiftyBidsGovernment contracts and grants, in one plain-English search.

Back to search

Forecast

Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)

The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC), including the participating Institutes, Centers and Offices, intend to publish a Notice of Funding Opportunity (NOFO) to invite eligible United States small business concerns (SBCs) to submit Small Business Innovation…

FromNational Institutes of Health
Who can applysmall businesses
How muchAmount not stated
DeadlineTue, Jan 5, 2027 (estimated) (74 days left)
CategoryHealth
TypeGrant
Opportunity #PAR-27-039
Assistance listing93.113, 93.121, 93.143, 93.172, 93.173, 93.213, 93.233, 93.273, 93.279, 93.350, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.859, 93.865, 93.866, 93.867, 93.879
PostedWed, May 27, 2026

Heads-up: Forecast: not open yet. Dates and amounts are the agency's estimates.

Open the official posting

From the notice

The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC), including the participating Institutes, Centers and Offices, intend to publish a Notice of Funding Opportunity (NOFO) to invite eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) Phase I, and Fast-Track (NIH only) grant applications for the Small Business Transition Grant. Through this NOFO, NIH and CDC will support early-career scientists as they transition into entrepreneurship. In addition to funding research and development efforts at the SBC, a major component of this NOFO is entrepreneurial training, mentoring, and career development of the PD/PI.Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop responsive projects, including identification of complementary industry mentors and career development resources. This NOFO will utilize the R43/R44 activity code. United States small businesses that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to begin to consider applying for this new NOFO. This opportunity is available to first-time Principal Investigators, and key personnel must include a mentor with measurable effort committed to the project.

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.